VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1353577
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: shingles; Rash has developed since receiving the vaccine; Feeling quite sore; This is a spontaneous report from a non-contactable consumer via a Pfizer sales representative. A 47-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date as an unknown dose number, at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced shingles on an unspecified date. It was also reported that rash has developed on an unspecified date since receiving the vaccine and that the patient was feeling quite sore. The patient was due to attend her physician on 13May2021.The outcome of the events was unknown. The event shingles was considered as medically significant. No follow up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1353578
Sex: F
Age:
State:

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: burning in her legs from the knee down/burning sensation in her left thigh/Intermittent burning sensations throughout her body in different spots; lower lip has intermittent numbness; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 12May2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date it was reported that since receiving her Pfizer-BioNTech COVID-19 vaccine on 12May2021. On 13May2021, she woke up with burning in her legs, from the knee down, that went away. Then she got a severe burning sensation in her left thigh. She reports that the burning sensation was ongoing but describes it as "Intermittent burning sensations throughout her body in different spots". She also reports her lower lip has intermittent numbness. The outcome of burning sensation (PT) was not recovered while for other event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353579
Sex: F
Age:
State: CT

Vax Date: 05/16/2021
Onset Date: 05/01/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: sore arm; a shooting pain towards her armpit going down her arm; chills; diarrhea; This is a spontaneous report from a contactable consumer (patient). A 41-years-old female patient received first dose of bnt162b2 (Pfizer-BioNTech Covid-19 Vaccine, Solution for injection), via an unspecified route of administration on 16May2021 (at an age of 41-years-old) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in May2021, the patient experienced sore arm, a shooting pain towards her armpit going down her arm, chills, diarrhea. Consumer reported that after receiving the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine yesterday, 16May2021, she had a sore arm, a shooting pain towards her armpit going down her arm, chills and diarrhea. She said she took Advil for her arm discomfort, but was told by a friend that she should not have taken the medication. She also said she was told that she should have taken Tylenol instead of Advil. She called to seek guidance regarding this. Consumer also said that in all the forms she has, there was no information about taking medications at the same time with taking the vaccine. Therapeutic measures were taken as a result of sore arm, a shooting pain towards her armpit going down her arm. The clinical outcome of the sore arm, a shooting pain towards her armpit going down her arm, chills, diarrhea were unknown.

Other Meds:

Current Illness:

ID: 1353580
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: metallic taste; This is a spontaneous report from a Pfizer-sponsored program support from a contactable consumer (patient). A 63 years old male patient received the second dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, lot. EN5318) at single dose, on an unspecified date, for COVID-19 immunization. Relevant medical history and concomitant medications were unknown. The patient previously, on 19Feb2021, received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, for COVID-19 immunization. After the first dose, the patient experienced soreness at point of injection. On an unspecified date, after the second dose, the patient experienced strong metallic taste. Clinical outcome of the adverse event was unknown at time of this report. No follow-up attempts are needed, no further information expected.

Other Meds:

Current Illness:

ID: 1353581
Sex: F
Age:
State: NC

Vax Date: 05/13/2021
Onset Date: 05/14/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Feeling terrible; Chills; Achiness; headache; Neck pain; Hip Hurts; freezing; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received second dose of bnt162b2 (PFIZER-Biontech Covid-19 Vaccine, Solution for injection, Lot Number: EW0182, Expiration date: 31Aug2021), dose 2 via an unspecified route of administration, administered in Arm Left on 13May2021 18:30 (Batch/Lot Number: EW0182; Expiration Date: 31Aug2021) as 2nd dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 14May2021, the patient experienced feeling terrible, chills, achiness, headache, neck pain, hip hurt, freezing. Caller reported dry skin and scaling inside to the outside of the ear after receiving the first dose of the Pfizer COVID-19 vaccine. She mentioned it's getting worst since the second dose. Caller is calling about the vaccination. She clarified it as the Covid vaccine. She is curious about the side effects. She got this on Thursday and still feels terrible. She still feel chills and achiness and freezing. She feels terrible from Thursday and everything is hurting her. The other thing, its a weird thing did anyone report dry and scaly-ness on the ear. She mentioned it to her cousin and her cousin mentioned she felt terrible as well and has Hives on her ears. They both had the same thing- dry skin and scaly-ness from the inside of the canal to the outside. She would like to know how to treat it. She has been putting things on it and its not going away and she wanted to know if someone else had the same thing. The other thing, its a weird thing did anyone report dry and scaly-ness on the ear. She has been putting things on it and its not going away and she wanted to know if someone else had the same thing. Feeling terrible treatment: no she thought it would wear off, it has been going on since thursday and now its monday, time: 1pm on Friday. For the chills treatment: she has been putting on extra cloths, time: she does not know exact time on Friday. Achiness treatment: none, time: friday in the afternoon. Headache, treatment: none, time: Friday in the afternoon. Neck pain caller stated its ongoing, outcome of event: Attempted to clarify with caller she stated she she still has it. It's not as bad as it was, treatment: none, time: Friday in the afternoon. Hip hurt caller stated it went away, outcome: caller stated unknown, treatment: none, time: afternoon. Dry and Scaly-ness of the Ear: Start - caller stated this is the second dose that started. The first dose she had 3 weeks ago. Stop - Its ongoing. Its gotten worse she is wondering if its related to the second dose of the vaccine. Treatment: steroid cream. She had it prescribed for something else. It didn't go away. She though it may heal this sore too. serial by the barcode - 51672404819. NDC: Prescription label on product. Caller unable to find NDC at this time. lot: 342227, exp: 09/2022, time: from the first one not the last one her ears are itching more since the second one. The clinical outcome of feeling terrible, chills, headache, freezing were not recovered, of the achiness, neck pain were recovering and of the hip hurts was unknown. Follow up attempts are needed. Further information has been requested.

Other Meds:

Current Illness:

ID: 1353582
Sex: F
Age:
State: FL

Vax Date: 05/13/2021
Onset Date: 05/16/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: armpit swelled up; This is a spontaneous report from a contactable other healthcare professional (patient). A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration, in right arm on 13May2021 at 12:00 PM (at the age of 31-years-old) as 2nd dose, single for COVID-19 immunization. Medical history included Tylenol allergy. Concomitant medications include release dietary supplements. The patient was not pregnant. No other vaccine was given in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. Historical vaccine includes BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date as first dose, single for COVID-19 immunization. The patient's armpit swelled up in the same side that he got the injection on 16May2021 (reported as three days after 2nd dose). The events were reported as non-serious. The patient did not receive any treatment for the event. The outcome of the event was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353583
Sex: M
Age:
State:

Vax Date: 02/05/2021
Onset Date: 02/27/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: flu symptoms; This is a spontaneous report from a non-contactable consumer (patient). A 42-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on 05Feb2021 13:15 (at the age of 42-years-old) as 2nd dose, single for COVID-19 immunization. Medical history included irritable bowel syndrome and zinc allergy. The patient's concomitant medications were not reported. No other vaccine was given in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date as first dose, single for COVID-19 immunization. The patient experienced flu symptoms after the second dose on 27Feb2021 07:00. The events were reported as non-serious. The patient did not receive any treatment for the events. The outcome of the event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1353584
Sex: F
Age:
State: MO

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: I was tired all the time; head ache; not hunger; lost 14 lbs; I didn't want to get out of bed/I didn't have any will to do anything.A shower was an effort; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number- er8736), via an unspecified route of administration on 26Apr2021 13:00 (at the age of 65-years-old) as unknown dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. No other vaccine was given in four weeks. Prior to vaccination the patient was not diagnosed with COVID-19. The patient reported that she didn't want to get out of bed, was tired all the time, headache, not hunger, lot 14 lbs, did not have the will to do anything and a shower was an effort on 27Apr2021 08:00 AM. The events were reported as non-serious. The patient did not receive any treatment for the events. The patient underwent lab tests and procedures which included nasal swab: negative on 05May2021. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1353585
Sex: F
Age:
State: HI

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Hearing go out and tinnitus in one ear intermittently for 2 weeks; Hearing go out and tinnitus in one ear intermittently for 2 weeks; Muscle jerking in arm, stomach, and one toe; Headache; This is a spontaneous report from a contactable other health care professional (patient). A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ER8731), via an unspecified route of administration in the left arm on 10Apr2021 at 00:00 (at the age of 41-years-old), 1st dose, single, for COVID-19 immunization. The patient had no medical history. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. The vaccine was administered at hospital. On 11Apr2021 at 13:00, the patient experienced hearing went out, tinnitus in one ear intermittently for two weeks; muscle jerking in arm, stomach, and in one toe and headache. The patient underwent lab tests and procedures which included nasal swab COVID-SARS PCR test: negative on 21Apr2021. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 1353586
Sex: F
Age:
State:

Vax Date:
Onset Date: 05/01/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Thought diarrhea might be due to lactose intolerance; Diarrhea; This is a spontaneous report from a contactable consumer (patient's son) via Medical Information Team. A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date, 1st dose, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In May2021 (last 2-3 days), the patient had diarrhea and the reporter took her to the doctor on 17May2021 and he asked if the patient had diarrhea (first occurrence) on that day and it had stopped in May2021. The reporter thought it might be due to lactose intolerance because the patient had a lot of ice cream. The patient did not have any signs of COVID-19 and they did not test her for COVID-19 at the doctor's office. The reporter was concerned because after they left the doctor's office they stopped and got something to eat. The patient was eating a lot of the dipping sauce and she had diarrhea (second occurrence) on 17May2021 at night. On 18May2021, at night, the patient was supposed to go and get second dose of the COVID-19 vaccine. The reporter was enquiring whether the patient was safe to receive the second dose or reschedule it. The outcome for the first occurrence of the event diarrhea was recovered in May2021 and that of second occurrence was unknown. The outcome of the event lactose intolerance was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353587
Sex: F
Age:
State: ID

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Body aches; Headache; Nausea; Fever; Dizziness; Injection site pain; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: unknown), via an unspecified route of administration in the left arm on 17May2021 at 17:30 (at the age of 27-years-old), 2nd dose, single, for COVID-19 immunization. Medical history included bronchitis, COVID-19, penicillin allergy and exercise endured asthma. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: unknown) administered via an unspecified route of administration on 26Apr2021 at 17:30 (at the age of 27-years-old), 1st dose, single for COVID-19 immunization. Prior to vaccination, the patient was diagnosed with COVID-19 but did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. The vaccine was administered at a pharmacy or drug store. On 18May2021 at 09:00, the patient experienced body aches, headache, nausea, fever, dizziness, and injection site pain. The events were reported as non-serious. The patient received unspecified over the counter medication and nurse directed to take rest. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353588
Sex: M
Age:
State: TX

Vax Date: 05/17/2021
Onset Date: 05/17/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: I'm really weak and grouchy; I'm really weak and grouchy; This is a spontaneous report from a contactable consumer (patient). An 18-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration in left arm on 17May2021 at 14:00 (at the age of 18-years-old) as 1st dose, single for COVID-19 immunization. Medical history included shrimp allergy. Concomitant medication included Ibuprofen. The patient was vaccinated at Hospital. No other vaccine was given in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. The patient reported that he was really weak and grouchy on 17May2021 17:00. The events were reported as non-serious. The patient did not receive any treatment for the events. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds: IBUPROFEN

Current Illness:

ID: 1353589
Sex: F
Age:
State: NJ

Vax Date: 05/17/2021
Onset Date: 05/01/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: bulging veins in wrists and hands; experiencing side effects with her veins looking like they are bulging in her legs, feet and ankles at first and they are now spreading to her hands.; Neck pain; Caller states the Vitamin E supplement that she takes can have a blood thinner property so she is not sure if that could have caused her reaction; This is a spontaneous report from a contactable consumer. A 60-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 17May2021 (Batch/Lot Number: EW0183; Expiration Date: 31Aug2021) as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included hypersensitivity and arthritis. Concomitant medication(s) included D-flame, Vitamin E, daily dose. The patient she has been experiencing side effects last night with her veins looking like they are bulging in her legs, feet and ankles at first and they are now spreading to her hands on 17May2021 22:00 and this morning the veins in her wrists and hands are bulging as well on 18May2021. She takes a daily supplement something like a multivitamin and she would like to know if the ingredients in the supplement could have caused an interaction with the vaccine? She states the Vitamin E supplement that she takes can have a blood thinner property so she is not sure if that could have caused her reaction. Ingredients of the supplement include holy basil 250 mg, turmeric 100 mg, ginger 100 mg, green tea 100 mg, baikal skullcap 50 mg, bromelain extract 100 mg, resveratrol 10 mg, berberine 5 mg and boswellia 100 mg. States the dosages provided are for two capsules and she only take one so it would be half. She said she really had bad neck pain last night on 17May2021. It was severe but went away after dinner. It was last evening, and she noticed it around 10:00pm. Took Tylenol before bed. She had nuclear stress test result unknown on 05May2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of event for bulging veins in wrists and hands was not resolved and for rest of the events it was unknown. Follow up needed, further information has been requested.

Other Meds: Vitamin E

Current Illness:

ID: 1353590
Sex: M
Age:
State: PA

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Fever - 103 degrees and tired; Fever - 103 degrees and tired; This is a spontaneous report from a contactable consumer (patient). A 12-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0168), intramuscular in left arm on 17May2021 15:00 (at the age of 12-years-old) as first dose, single for COVID-19 immunization. Medical history was none. The patient had no known allergies. Concomitant medication included fexofenadine hydrochloride (ALLEGRA). Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks prior. The patient experienced fever - 103 degrees and tired on 18May2021 12:00. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. Outcome of the event was unknown.

Other Meds: ALLEGRA

Current Illness:

ID: 1353591
Sex: M
Age:
State: NY

Vax Date: 02/19/2021
Onset Date: 03/04/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in right arm on 19Feb2021 at 12:00 (at the age of 71-years-old) as first dose, single (Lot number- EN6200); and via an unspecified route of administration in right arm on 12Mar2021 at 12:00 (at the age of 71-years-old) as second dose, single (Lot number- EN6206), both for COVID-19 immunization. Medical history included primary biliary cholangitis and prostate cancer. Concomitant medications included Ursodiol, hydrochlorothiazide and losartan potassium. The patient did not have any known allergies. No other vaccine was given in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. The patient experienced severe vertigo 13 days after first vaccine, as 04Mar2021 08:00, and again 12 days after second vaccine (24Mar2021). The events were reported as non-serious. Therapeutic measures taken as a result of the event included Meclazine. The outcome of the event was recovered on unspecified date.

Other Meds: URSODIOL; HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Current Illness:

ID: 1353592
Sex: F
Age:
State: PA

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Extremely sore arm, can not move it at all without people in pain; Extremely sore arm, can not move it at all without people in pain; This is a spontaneous report from a contactable consumer (patient). A 22-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number was unknown and expiration date was not reported), via an unspecified route of administration, in Left Arm on 17May2021 at 19:00 (at the age of 22-years old) at first dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient experienced extremely sore arm, can not move it at all without people in pain on 18May2021 after the first dose and did not had any other side effects. The event was reported as non serious. No treatment was received for the event. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353593
Sex: F
Age:
State: CO

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), intramuscularly in right arm on 27Apr2021 at 11:30 (at the age of 62-years-old), 2nd dose, single, for COVID-19 immunization. Medical history included anaphylactic allergies to peanuts and all its products. Concomitant medication included unspecified vitamins. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered intramuscularly on 06Apr2021 at 11:30, 1st dose, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. The vaccine was administered at hospital. On 28Apr2021 at 00:00, the patient felt like there was a 6 to 8-inch-wide rubber band that was too small and tight around her knees, wrists, elbows, ankles, and feet. The patient had a lot of pain in all joint areas, in between each joint there were waves of being extremely achy and there were waves of a tingling feeling, for example like when the foot falls asleep. The patient reported that the pain was so much, and she just laid still in bed the next 20 hours without moving much. On 29Apr2021, the following day after the pain, the patient was just wrenched and exhausted. The patient had a big stuffy and achy in the head area. On 18May2021, at night the patient felt every sensation came back, but not as severe as earlier. The events were reported as non-serious. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353594
Sex: M
Age:
State: GA

Vax Date: 05/12/2021
Onset Date: 05/01/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: stiff neck and headache; extreme fatigue after second dose; stiff neck and headache; falling asleep in the chair; This is a spontaneous report from a contactable consumer (patient's wife). A male patient in his 60s received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EW0173), via an unspecified route, administered in left arm on 12May2021, as second dose, single for COVID-19 immunization. The patient did not have relevant medical history and did not receive concomitant medications. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EP6955), via an unspecified route, in Apr2021, as first dose, single for COVID-19 immunization and experienced headache and really stiff necks. On an unknown date in May2021, the patient experienced stiff neck and headache which the patient expected as it occurred after the first dose. On an unknown date in May2021, the patient experienced extreme fatigue for several days after the second dose, more than normal, and the patient was falling asleep in the chair. The outcome was unknown for the reported events at the time of reporting.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021565416 same patient/reporter/suspect; different dose/AE

Other Meds:

Current Illness:

ID: 1353595
Sex: F
Age:
State: VA

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Fever (103.4); chills; nausea; injection site pain; fatigue; severe headache; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0179), dose 2 via an unspecified route of administration in left arm on 15May2021 15:15 (at the age of 33-years-old) as second dose, single for COVID-19 immunization. The patient medical history was not reported. The patient have no known allergies. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0172), dose 1 via an unspecified route of administration in left arm on 25Apr2021 03:30 PM (at the age of 33-years-old) as first dose, single for COVID-19 immunization. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks nor any other medications within two weeks prior. The patient experienced fever (103.4), chills, nausea, injection site pain, fatigue and severe headache on 16May2021 04:00. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. Outcome of the events was resolving.

Other Meds:

Current Illness:

ID: 1353596
Sex: M
Age:
State: NJ

Vax Date: 04/30/2021
Onset Date: 05/06/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number- EQ0170), via an unspecified route of administration in left arm on 30Apr2021 08:00 (at the age of 38-years-old) as 2nd dose, single for COVID-19 immunization. Medical history included amoxicillin allergy, penicillin allergy and allergy to sulfa drugs. The patient's concomitant medications were not reported. No other vaccine was given in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number- EP7533), via an unspecified route of administration in left arm in Apr 2021 08:00 (at the age of 38-years-old) as 1st dose, single for COVID-19 immunization. The patient experienced left arm joint muscle pain at site of injection, moderate, limiting use and full body joint pain in knees, back and ankles, moderate, limiting use on 06May2021 12:00 AM. The events were reported as non-serious. The patient did not receive any treatment for the events. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 1353597
Sex: F
Age:
State:

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Strange metallic taste in my mouth and heartburn; Strange metallic taste in my mouth and heartburn; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number was ewo153 and expiration date was not reported), via an unspecified route of administration, in Left Arm on 26Apr2021 (at the age of 63-year-old) at 10:00 at 1ST DOSE, single for covid-19 immunization. Medical history included mitral valve prolapse and osteoarthritis. Concomitant medications included venlafaxine hydrochloride (EFFEXOR) 75mg and colecalciferol (VITAMIN D [COLECALCIFEROL]) 5000 ui received within 2 weeks of vaccination. The patient previously took iodine and erythromycin and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Patient was not pregnant at the time of vaccination. The patient experienced strange metallic taste in her mouth and heartburn on 26Apr2021 at 10:15 after the first dose. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovered in Apr2021.

Other Meds: EFFEXOR; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 1353598
Sex: F
Age:
State: GA

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0182), via an unspecified route of administration in the left arm on 14May2021 at 12:00 (at the age of 55-years-old), 1st dose, single, for COVID-19 immunization. The patient had no medical history. Concomitant medication included quetiapine fumarate (SEROQUEL). The patient previously took zithromax z-pack and experienced drug hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. On 15May2021 at 07:00, the patient started experiencing severe back pain and on 18May2021 she developed a weltish rash all over her lower back. As of the day of report, the patient was still experiencing back pain. The events were reported as non-serious and resulted in doctor or other healthcare professional office/clinic visit. The patient had three visits to chiropractor to relieve back pain. The patient had not been tested for COVID-19 since vaccination. The outcome of the event severe back pain was not recovered and that of another event was unknown.

Other Meds: SEROQUEL

Current Illness:

ID: 1353599
Sex: F
Age:
State: VA

Vax Date: 03/28/2021
Onset Date: 04/05/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; ringing will decrease, increase and will even become muffled; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), dose 2 via an unspecified route of administration in left arm on 28Mar2021 09:00 (at the age of 30-years-old ) as second dose, single for COVID-19 immunization. Medical history included known allergies. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198) via an unspecified route of administration in left arm on 07Mar2021 08:45 as first dose, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. The patient received some other medications within two weeks prior to vaccination. On 05Apr2021, the patient's ears began to pop, hurt, and itch then started ringing intermittently within a week of taking the second COVID-19 dose. Shortly thereafter, they began to ring continuously and hadn't stopped. Sometimes the ringing will decrease, increase and will even become muffled and things will sound like she was under water. She had been seen at urgent care twice for this issue and now scheduled to see an ENT on 20May2021 at 3:15PM. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on an unspecified date, post vaccination. Events were treated with two rounds of antibiotics. Outcome of the events were not resolved. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353600
Sex: F
Age:
State: IA

Vax Date: 05/13/2021
Onset Date: 05/15/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Vaginally bleeding x4 days; diarrhea x 2 mornings; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0179 and expiration date was not reported), via an unspecified route of administration in right arm, on 13May2021 at 10:30 (at the age of 46 years old) as 1st dose, single for COVID-19 immunization in a hospital. Medical history included colon polyps, bipolar II disorder, inattentive add and early cardio disease. Concomitant medications included sertraline hydrochloride (ZOLOFT); amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); sulfamethoxazole (+) trimethoprim (BACTRIM) and ibuprofen. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient was pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was never tested for COVID-19. The patient experienced vaginal bleeding for 4 days and diarrhea for 2 mornings on 15May2021 at 10:00. The events were assessed as non-serious by the reporter. No treatment was received by the patient regarding these events. The outcome of these events was recovering at the time of report.

Other Meds: ZOLOFT; ADDERALL; BACTRIM; IBUPROFEN

Current Illness:

ID: 1353601
Sex: F
Age:
State: NJ

Vax Date: 05/11/2021
Onset Date: 05/19/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Tingling in face; headache; sneezing; itching; light headness and dizzy; lips swelling; eye swelling; like an allergies; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0173 and expiration date was not reported), via an unspecified route of administration in right arm, on 11May2021 at 10:45 (at the age of 66 years old) as first dose, single for COVID-19 immunization in a hospital. Medical history included stage 3 kidney disease, systemic lupus erythematosus, high blood pressure and thyroidectomy. The patient's known allergies: penicillin. The patient previously took dilaudid and prednisone; and experienced drug allergy. Concomitant medications included levothyroxine sodium (SYNTHROID); hydroxychloroquine sulfate (PLAQUENIL); metoprolol; famotidine and alprazolam (ALPRAZ). The patient was not pregnant at the time of vaccination and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The patient experienced tingling in face, headache, sneezing, itching, light headedness/dizzy, lips swelling, eye swelling and had like an allergies on 19May2021 at 09:00. This case was considered non-serious and no treatment was given for these events. The outcome of these events was not recovered at the time of report.

Other Meds: SYNTHROID; PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; METOPROLOL; FAMOTIDINE; ALPRAZ

Current Illness:

ID: 1353602
Sex: M
Age:
State:

Vax Date: 05/15/2021
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Covid arm. red blotchy arm on arm that had shot; This is a spontaneous report from a non-contactable consumer (patient). A 65-year-old male patient received BNT162B2 (PFIZER COVID-19 VACCINE, lot number: unknown), at the age of 65 years old, at single dose on 15May2021 13:45 for covid-19 immunisation. The patient had no known allergies. The patient was not diagnosed with covid-19 prior to vaccination. The patient experienced covid arm, red blotchy arm on arm that had shot on an unspecified date. The patient had not been tested for covid-19 since the vaccination. No treatment was received. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1353603
Sex: F
Age:
State: MI

Vax Date: 05/17/2021
Onset Date: 05/17/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: high fever - 102 F; very swollen and painful lymph nodes in left armpit and right but not as bad sweaty feet; very swollen and painful lymph nodes in left armpit and right but not as bad sweaty feet; very swollen and painful lymph nodes in left armpit and right but not as bad sweaty feet; abnormal horrific headache; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0179 and expiration date was not reported), via an unspecified route of administration in left arm, on 17May2021 at 14:30 (at the age of 40 years old) as second dose, single for COVID-19 immunization in a Public Health Clinic/Veterans Administration facility. The patient's medical history was not reported. The patient previously took prochlorperazine maleate (COMPAZINE) and experienced drug allergy. Concomitant medications included esomeprazole sodium (NEXIUM) and celecoxib (CELEXA). Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0172 and expiration date was not reported), via an unspecified route of administration in left arm, on Apr2021 at 10:30 (at the age of 40 years old) as first dose, single for COVID-19 immunization. The patient was not pregnant at the time of vaccination and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown if the patient diagnosed with COVID-19 and post-vaccination, the patient was tested for COVID-19 with nasal swab and the result was negative on 16Apr2021. The patient experienced high fever with a temperature of 102 F, very swollen and painful lymph nodes in left armpit and right but not as bad sweaty feet and abnormal horrific headache on 17May2021 at 14:30. This case was considered as non-serious and no treatment was given to the patient for these events. The outcome of these events was recovering at the time of report.

Other Meds: NEXIUM; CELEXA

Current Illness:

ID: 1353604
Sex: M
Age:
State: CO

Vax Date: 05/17/2021
Onset Date: 05/19/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Vomiting; This is a spontaneous report from a contactable consumer (patient). A 13-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0187 and expiration date was not reported), via an unspecified route of administration in left arm, on 17May2021 at 16:45 (at the age of 13 years old) as 1st dose, single for COVID-19 immunization in a pharmacy/drug store. The patient's medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was never tested for COVID-19. The patient experienced vomiting on 19May2021. This event resulted in doctor or other healthcare professional office/clinic visit. The event was non-serious. It was reported that the patient received an unspecified treatment for this event. The outcome of the event was recovering at the time of report.

Other Meds:

Current Illness:

ID: 1353605
Sex: M
Age:
State:

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: fever; body pain; This is a spontaneous report from a contactable consumer (patient's son). A 40-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0169 and expiration date was reported), via an unspecified route of administration in arm (reported as shoulder), on 18May2021 between 14:00 to 15:00 (at the age of 40 years old) as second dose, single for COVID-19 immunization in the patient's home. The vaccine was not administered in a military facility. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ER8731 and expiration date was reported), via an unspecified route of administration in shoulder, on 26Apr2021 (at the age of 40 years old) as first dose, single for COVID-19 immunization. No other vaccinations was administered within four weeks prior to the first dose of the COVID-19 vaccine. The patient experienced body pain on the night of 18May2021 and fever on 19May2021. The patient events did not require emergency room (ER)/physician's office. The outcome of fever was unknown and body pain was not recovered at the time of report. No follow attempts are possible; no further information is expected.

Other Meds:

Current Illness:

ID: 1353606
Sex: F
Age:
State: KS

Vax Date:
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Fever; This is a spontaneous report from a contactable consumer (patient's son). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, unknown formulation) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The caller stated that his mother had a fever after getting the Covid-19 vaccine. The outcome of the event was unknown. Information related to lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353607
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Chills; Sickness; I got the soreness/I am achy, the achiness; upset stomach; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 AVCCINE; lot number and expiration date were not reported), via an unspecified route of administration, on an unspecified date as unknown dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced chills, sickness, got soreness/had achy, the achiness and upset stomach on an unspecified date. The patient just wondering what can she do about it. The outcome of these events was unknown at the time of report. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1353608
Sex: F
Age:
State: IL

Vax Date: 12/29/2020
Onset Date: 01/19/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Very sore arm; Swollen lymph nodes; Felt sick; This is a spontaneous report from a contactable healthcare professional (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: Ej1685), intramuscularly in left arm on 29Dec2021 (at the age of 34-years-old), 1st dose, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. The vaccine was administered at a workplace clinic. On 19Jan2021, the patient had a very sore arm, swollen lymph nodes and felt sick for weeks. The events resulted in doctor or other healthcare professional office/clinic visit. After the first dose the patient was put in medications (unspecified) to help to prevent the same symptoms with second dose. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was unknown. Information on Lot/batch number was available. Additional information has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021570459 same reporter/patient/vaccine, different dose

Other Meds:

Current Illness:

ID: 1353609
Sex: F
Age:
State: MS

Vax Date: 04/17/2021
Onset Date: 04/21/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Pressure and blurry vision in my right eye; Pressure and blurry vision in my right eye; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female (no pregnant) patient received the first dose of BNT162B2 via an unspecified routed of administration on the right arm on 17Apr2021 at 13:15 (Lot Number: EW0250) as single dose for COVID-19 immunization. Medical history included rheumatoid arthritis. Known allergies is sulfa. The patient was not diagnosed with COVID-19 prior vaccination. The patient had not been tested for COVID-19 post vaccination. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included hydroxychloroquine (PLAQUENIL). On 21Apr2021 at 12:00, the patient experienced pressure and blurry vision in right eye. The treatment was not received. The adverse event result in doctor or other healthcare professional office/clinic visit. The outcome of events was both not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: PLAQUENIL

Current Illness:

ID: 1353610
Sex: F
Age:
State: PA

Vax Date: 05/19/2021
Onset Date: 05/19/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Patient felt dizzy after couple of minutes of receiving the vaccine.; This is a spontaneous report from a non-contactable consumer (patient). A 12-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EW0185), via an unspecified route of administration at right arm on 19May2021 (at the age of 12-year-old) as unknown, single for COVID-19 immunisation. Medical history included allergies: Cashews. Patient other medical history was none. The patient's concomitant medications were not reported. Facility where the most recent COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19May2021, patient felt dizzy after couple of minutes of receiving the vaccine. Treatment was not received for the adverse event. Due to event Doctor or other healthcare professional office/clinic visit. The events were assessed as non-serious, did not result in death, not life threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. The outcome of the event was recovered in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1353611
Sex: F
Age:
State: TN

Vax Date: 12/23/2020
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: mild cough with throat irritation for about 3 weeks; mild cough with throat irritation for about 3 weeks; This is a spontaneous report from a contactable other health care professional (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730), via an unspecified route, administered in right arm on 23Dec2021 at 08:00 (at the age of 30-year-old), as first dose, single, for COVID-19 immunization at hospital. Medical history included rheumatoid arthritis. Concomitant medications included ibuprofen (IBUPROFEN) and certolizumab pegol (CIMZIA). The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was never tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced mild cough with throat irritation for about 3 weeks on an unspecified date. The outcome was reported as recovered on an unknown date of 2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021576704 same patient, different event, different dose of vaccine

Other Meds: IBUPROFEN; CIMZIA

Current Illness:

ID: 1353612
Sex: F
Age:
State: NC

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: insomnia; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: el64 and expiration date was not reported), via an unspecified route of administration in left arm, on 13Feb2021 (at the age of 71 year old) as 2nd dose, single for COVID-19 immunization. Medical history included penicillin allergy. Concomitant medications included fluoxetine hydrochloride (PROZAC) and hydrochlorothiazide. The patient previously took erythromycin and experienced drug allergy. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: 3247 and expiration date was not reported), via an unspecified route of administration in left arm, on 23Jan2021 (at the age of 71 year old) as 1st dose, single for COVID-19 immunization. The patient was not pregnant at the time of vaccination and did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The patient experienced insomnia in the evening on 13Feb2021 and continued for 3 months. Slowly getting back to normal which is when the patient fall asleep within a few minutes after going to bed. It was reported that the patient would still take the vaccine again. The event was considered to be non-serious. No treatment was given for this event. The outcome of the event was recovering at the time of report.

Other Meds: PROZAC; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1353613
Sex: F
Age:
State: IA

Vax Date: 05/20/2021
Onset Date: 05/20/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Abnormal thought process; This is a spontaneous report from a non-contactable consumer (patient). A 26-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EW 0172), via an unspecified route, administered in left arm on 20May2021 at 08:15 (at the age of 26-year-old) as 2ND DOSE, SINGLE for COVID-19 immunization. Medical history included attention deficit hyperactivity disorder (ADHD), depression and anxiety. There were no concomitant medications. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8736), via an unspecified route, administered in left arm on 28Apr2021 at 10:00 (at the age of 26-year-old) as 1ST DOSE, SINGLE for COVID-19 immunization. The patient did not receive any other medications the patient within 2 weeks of vaccination. The patient was not pregnant at the time of vaccination. The patient did not have any allergies. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was never tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20May2021 at 12:00, the patient had abnormal thought process. The events were reported as non serious. The outcome was not recovered for the reported event. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1353614
Sex: M
Age:
State: OH

Vax Date: 05/17/2021
Onset Date: 05/18/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Abdominal pain that comes and goes; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: FW0182 and expiration date was not reported), via an unspecified route of administration in left arm, on 17May2021 at 11:30 (at the age of 34 year old) as 2nd dose, single for COVID-19 immunization in a Pharmacy or Drug Store. Medical history included penicillin allergy. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: unknown and expiration date was not reported), via an unspecified route of administration in right arm, on 20Apr2021 at 11:30 (at the age of 34 year old) as 1st dose, single for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The patient experienced abdominal pain that comes and goes on 18May2021 at 12:00. The event was considered non-serious. No treatment was received for this event. The outcome of the event was not recovered at the time of report.

Other Meds:

Current Illness:

ID: 1353615
Sex: F
Age:
State: TX

Vax Date: 05/19/2021
Onset Date: 05/20/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Body aches; loss of appetite; tinnitus; This is a spontaneous report from a contactable consumer (patient). A 21-year-old female patient received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), dose 2 via an unspecified route of administration in left arm on 19May2021 13:45 (at the age of 21-years-old) as second dose, single for COVID-19 immunization. Medical history included COVID-19. Historical vaccine included BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), dose 1 via an unspecified route of administration in left arm on 28Apr2021 13:45 as first dose, single for COVID-19 immunization. Prior to vaccination, the patient did not receive any vaccines within four weeks and was not pregnant. Concomitant medications included lorazepam, gabapentin, and mirtazapine. The patient experienced body aches, loss of appetite and tinnitus on 20May2021 12:00. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the events. Outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds: LORAZEPAM; GABAPENTIN; MIRTAZAPINE

Current Illness:

ID: 1353616
Sex: F
Age:
State:

Vax Date: 05/19/2021
Onset Date: 05/20/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Headache; Episode of stiffness, going pale; Episode of stiffness, going pale; 15 seconds of memory loss; This is a spontaneous report from a non-contactable female other HCP reported for herself. A 19-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via intramuscular route of administration on 19May2021 16:45 (at the age of 19-year-old) as single dose for COVID-19 immunization. Medical history was none, and no allergies were reported. Concomitant medication included sarecycline(SARECYCLINE) contraceptive pill via oral route of administration. On 20May2021 11:00 AM, the patient experienced headache, episode of stiffness, going pale, 15 seconds of memory loss. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment medications for events. It was unknown whether the patient received any other vaccines within 4 weeks prior to the COVID vaccine, diagnosed with COVID-19 prior to vaccination and has been tested for COVID-19 since the vaccination. The events were reported as non-serious. Outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds: SARECYCLINE

Current Illness:

ID: 1353617
Sex: F
Age:
State: NC

Vax Date: 05/14/2021
Onset Date: 05/17/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Nausea; vomiting; This is a spontaneous report from a contactable physician. A 14-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0182), dose 1 via an unspecified route of administration on 14May2021 (at the age of 14-years-old ) as first dose, singe for COVID-19 immunization. Medical history included gluten allergy. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. The patient experienced nausea and vomiting on 17May2021 11:00. Since the vaccination, patient has not been tested for COVID-19. The events resulted in physician or other healthcare professional office/clinic visit and was treated with oral Ondansetron. Outcome of the events were resolved.

Other Meds:

Current Illness:

ID: 1353618
Sex: F
Age:
State:

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: dizziness/started getting dizzy; vertigo; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiration date were not reported), via an unspecified route of administration on 22Apr2021 at first dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient started getting dizzy on 22Apr2021, 2 hours after the first dose. The patient also stated that she had a unique reaction and experienced dizziness and vertigo for 14 days after getting the first dose. it had gotten better, and she did not have the symptoms anymore. The primary care provider suggested she pushed the second dose back, so patient would be getting the second dose on 21May2021 at 5 weeks after the first dose. Additionally, she wanted to know information or guidance regarding dizziness and the second dose. The outcome of the events was recovered in May2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353619
Sex: M
Age:
State: ME

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: right leg/knee became severely swollen; right leg/knee became severely swollen; couldn't walk; fatigue; fever; aches; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN5318), via an unspecified route of administration, administered in left arm on 18Feb2021 at 12:00 (at the age of 74-year-old), as first dose, single, for COVID-19 immunization at school or student health clinic. Medical history included high blood pressure. The patient had no known allergies. Concomitant medications included atorvastatin calcium (LIPITOR); morniflumate (FLOMAX) losartan potassium (LOSARTAN POTASSIUM) and plus more (unspecified). Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was never tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's right leg/knee became severely swollen and he couldn't walk and also the patient had fatigue, fever and aches on an unspecified date on 2021. The events were reported as non-serious. No treatment was received for the events. The outcome was reported as recovered on an unknown date in 2021 for the reported events.

Other Meds: LIPITOR; FLOMAX; LOSARTAN POTASSIUM

Current Illness:

ID: 1353620
Sex: F
Age:
State: TN

Vax Date: 01/13/2021
Onset Date: 01/18/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: chronic urticaria began and has not stopped; increase thyroid antibodies; This is a spontaneous report from a contactable other health care professional (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142), via an unspecified route, administered in right arm on 13Jan2021 at 08:00 (at the age of 30-year-old), as second dose, single, for COVID-19 immunization at hospital. Medical history included rheumatoid arthritis. Concomitant medications included ibuprofen (IBUPROFEN) and certolizumab pegol (CIMZIA). The patient was not pregnant at the time of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730), via an unspecified route, administered in right arm on 23Dec2020 at 08:00 (at the age of 30-year-old), as single dose, for COVID-19 immunization and experienced mild cough with throat irritation for about 3 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was never tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Jan2021, 5 days after the second vaccination, chronic urticaria started and had not stopped as well as increase thyroid antibodies was reported. The events were reported as non serious and resulted in Doctor or other healthcare professional office/clinic visit. At the time of the report the patient was receiving unspecified medications for the events. The outcome was not recovered for the reported events.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021575962 same patient, different event, different dose of vaccine

Other Meds: IBUPROFEN; CIMZIA

Current Illness:

ID: 1353621
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Sore arm.; This is a spontaneous report from a Pfizer sponsored program COVAX US support received from a contactable consumer reporting for her husband. A male patient of an unspecified age received BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, via an unspecified route of administration on an unspecified date (Batch/Lot Number: not provided) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced sore arm. The event outcome was unknown at the time of the report. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353622
Sex: M
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Tired/fatigue; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program COVAX US support and Medical Information Team. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on Monday (an unspecified date), 2nd dose, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was wondering why he was experiencing severe side effects, due to people telling him side effects happened 1 to 3 days after Pfizer COVID-19 vaccine. The patient felt only a bit tired and fatigue. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353623
Sex: M
Age:
State:

Vax Date: 04/14/2021
Onset Date: 04/01/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: scratching; his injection site on the left arm had a wheal; some rashes on his left arm; the rashes are still there and is now up to his face; developed scabs that are now bleeding; This is a spontaneous report from a Pfizer. A contactable consumer (patient) reported that a 77-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Apr2021 as 2ND DOSE, SINGLE for covid-19 immunization. The patient previously received first dose of BNT162B2 (Solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration (at the age of 77 years) in right arm on 23Mar2021 for covid-19 immunization and experienced his injection site on his right arm also had a wheal. Patient had no allergies to anything. Patient consulted with his regular dermatologist on 27Apr2021 and doctor noticed that he was scratching. On an unspecified date in Apr2021, patient experienced his injection site on the left arm had a wheal and there had been some rashes on his left arm; rashes are still there and is now up to his face. They are not healing and he had developed scabs that are now bleeding. Therapeutic measures were taken, prescribed a cream for 2 weeks as a result of scratching, his injection site on the left arm had a wheal, some rashes on his left arm; the rashes are still there and is now up to his face with cream for 2 weeks. The events assessed as non-serious. The clinical outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353624
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: tooth abscess; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number and expiration date was not reported), dose 1 via an unspecified route of administration on an unspecified date as 1ST DOSE, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient is scheduled to get the second dose of the Pfizer covid vaccine on Monday, but on an unspecified date she experienced a tooth abscess. Patient wanted to know if its ok to take the second dose. The outcome of event was unknown. Follow-up attempts are needed; information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1353625
Sex: F
Age:
State: FL

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Swollen tongue and metallic taste; Swollen tongue and metallic taste; This is a spontaneous report from a contactable HCP (patient). A 45-year-old female (no pregnant) patient received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 18May2021 at 09:45 (Lot Number: 59267100001) as single dose for COVID-19 immunization. Relevant medical history and concurrent conditions included seasonal allergies-asthma. Known allergies is sulfas. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included fexofenadine hydrochloride (ALLEGRA). The patient experienced swollen tongue and metallic taste on 18May2021 at 10:45. The adverse event result in doctor or other HCP office/clinic visit. The steroids had been received as treatment for the adverse events. The outcome of events was recovered on an unspecified date. No attempts are possible. No further information is expected.

Other Meds: ALLEGRA

Current Illness:

ID: 1353626
Sex: F
Age:
State:

Vax Date: 05/19/2021
Onset Date: 05/21/2021
Rec V Date: 05/27/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Lip swelling and pain/swollen to 4x the regular size of lip; Lip swelling and pain/swollen to 4x the regular size of lip; This is a spontaneous report from a non-contactable consumer (patient, herself). A 31-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: EW0178 and expiry date was not provided), via an unspecified route of administration, administered in Arm Left on 19May2021 13:15 (at the age of 31-years old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. Since the vaccination, the patient had been tested for COVID-19. No known allergies. No other medical history. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. On 21May2021 12:00 AM, the patient experienced lip swelling and pain, swollen to 4 times the regular size of lip. No treatment received for the events. Seriousness of the events was reported as non-serious. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am